Cantor Fitzgerald analyst Deepak Mathivanan reiterated a Buy rating on Amazon yesterday and set a price target of $280.00. The company’s shares closed yesterday at $234.11. Take advantage of TipRanks ...

Fintel reports that on August 1, 2025, Cantor Fitzgerald initiated coverage of USA Rare Earth (NasdaqGM:USAR) with a ...

Tenable Holdings, Inc. (NASDAQ:TENB) is one of the Best Cybersecurity Stocks to Buy Under $100. On July 24, Cantor Fitzgerald ...

Ardelyx Inc. (NASDAQ:ARDX) is one of the penny stocks that will skyrocket. On July 7, analysts at Cantor Fitzgerald ...

Following an exceptionally strong second-quarter earnings report and optimistic third-quarter guidance issued on Wednesday, Meta Platforms (NASDAQ:META) has seen a wave of positive reratings and ...

A potentially billion-dollar acquisition of Gilgamesh Pharmaceuticals suggests big pharma may finally be willing to place ...

AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast ...

Fintel reports that on July 30, 2025, Cantor Fitzgerald upgraded their outlook for Replimune Group (NasdaqGS:REPL) from ...

Crypto investment firm Twenty One Capital is considering plans to issue U.S. dollar loans backed by Bitcoin collateral, ...

Cantor Fitzgerald LP affiliates Newmark Group Inc. and BGC Group Inc. are suing to seize equity from a commercial real estate ...

Replimune (NASDAQ:REPL) stock surges as Cantor Fitzgerald upgrades, citing improved odds for approval of its lead drug after an FDA leadership change. Read more here.

Twenty One Capital is reportedly considering offering US dollar loans backed by Bitcoin, as its BTC holdings surpass 43,500 ...